Clinical Trial Update: Evaluation of Immediate-Release Viloxazine in Adults With ADHD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials evaluating immediate-release viloxazine in adults with ADHD have completed, and results were posted in October 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Viloxazine (immediate-release) (viloxazine)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-10-15